The final phase of a clinical trial aiming to treat familial Alzheimer's disease using existing medication for Parkinson's ...

New study tests Parkinson’s drug to treat early-onset familial Alzheimer’s disease, a rare form of dementia, with results ...

Three BriaCell posters and one publish-only abstract highlight robust clinical data from Bria-IMT™ and Bria-OTS™ studies in ...

Following these outcomes, Sun Pharma has decided to discontinue further clinical trials of SCD-044 and has no plans for its ...

| When clinical trial steps are managed separately, the study suffers from compounded delays. Discover proven solutions from ...

A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...

An innovative new treatment for tackling some of the toughest stomach cancers has shown promise in a phase 2 clinical trial, ...

START and OneOncology launch 3 new early-phase trial sites, expanding access to new cancer research in community oncology ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

Sun Pharmaceutical Industries is discontinuing two trials of its drug candidate SCD-044 for moderate to severe as psoriasis ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs ...